Matches in Wikidata for { <http://www.wikidata.org/entity/Q59352196> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q59352196 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q59352196 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59352196 description "scientific article published on 01 September 2018" @default.
- Q59352196 description "wetenschappelijk artikel" @default.
- Q59352196 description "наукова стаття, опублікована у вересні 2018" @default.
- Q59352196 name "Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C" @default.
- Q59352196 name "Impact of direct acting antiviral" @default.
- Q59352196 type Item @default.
- Q59352196 label "Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C" @default.
- Q59352196 label "Impact of direct acting antiviral" @default.
- Q59352196 prefLabel "Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C" @default.
- Q59352196 prefLabel "Impact of direct acting antiviral" @default.
- Q59352196 P1433 Q59352196-40078D08-36E8-4AB1-9CE4-0DA1846C1874 @default.
- Q59352196 P1476 Q59352196-3C32EF70-9C8E-4B7F-8CF9-8C27150D72F2 @default.
- Q59352196 P2093 Q59352196-1AEDB9F8-5E7F-4263-BD6C-030B790F01CC @default.
- Q59352196 P2093 Q59352196-9AD66F06-95B0-4FB3-B3DB-3B87DB362B27 @default.
- Q59352196 P2093 Q59352196-A16C5338-0B16-4FE4-84D5-129297A4AE8D @default.
- Q59352196 P2093 Q59352196-AB068AF3-980B-4B04-8198-F9AB42DDD136 @default.
- Q59352196 P2093 Q59352196-B988A680-22EA-4167-BC48-966681C8A49A @default.
- Q59352196 P2093 Q59352196-CE5FF2AF-5CAF-4DB1-A85D-9AEDD8E8BAEE @default.
- Q59352196 P2093 Q59352196-CEB2F838-1B85-4E71-BF45-BB698C42C5C5 @default.
- Q59352196 P304 Q59352196-E977B35B-5489-4CD8-B3AA-AFD2A256432A @default.
- Q59352196 P31 Q59352196-2D9D833B-88AB-4B4B-AB98-FAE38AA262EF @default.
- Q59352196 P356 Q59352196-91D2EE2C-887B-4EC0-A5D1-669FA68B3DED @default.
- Q59352196 P407 Q59352196-7A012FF1-BAA1-4865-ADDE-FA83675F08B3 @default.
- Q59352196 P433 Q59352196-A99CF1D9-3809-47F5-8E5D-B866211AB16B @default.
- Q59352196 P478 Q59352196-DFF78B59-61C0-4A9C-A3FA-2CADA3BC79A8 @default.
- Q59352196 P577 Q59352196-24FAB9B1-C8F5-4A31-9C19-81EC9C197BA6 @default.
- Q59352196 P698 Q59352196-BF06194A-4790-40A9-A4D9-2364462A6121 @default.
- Q59352196 P921 Q59352196-1EF43FE7-D5CD-41F6-BE6C-1B333A94D127 @default.
- Q59352196 P356 JGLD.2014.1121.273.DAA @default.
- Q59352196 P698 30240472 @default.
- Q59352196 P1433 Q26853901 @default.
- Q59352196 P1476 "Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C" @default.
- Q59352196 P2093 "Andreas Teufel" @default.
- Q59352196 P2093 "Christoph Antoni" @default.
- Q59352196 P2093 "Dominik Boettche" @default.
- Q59352196 P2093 "Elke Burgermeister" @default.
- Q59352196 P2093 "Matthias P A Ebert" @default.
- Q59352196 P2093 "Philip Weidner" @default.
- Q59352196 P2093 "Thomas Zimmerer" @default.
- Q59352196 P304 "281-289" @default.
- Q59352196 P31 Q13442814 @default.
- Q59352196 P356 "10.15403/JGLD.2014.1121.273.DAA" @default.
- Q59352196 P407 Q1860 @default.
- Q59352196 P433 "3" @default.
- Q59352196 P478 "27" @default.
- Q59352196 P577 "2018-09-01T00:00:00Z" @default.
- Q59352196 P698 "30240472" @default.
- Q59352196 P921 Q55779873 @default.